150 related articles for article (PubMed ID: 37735585)
1. Development of artificial intelligence prognostic model for surgically resected non-small cell lung cancer.
Kinoshita F; Takenaka T; Yamashita T; Matsumoto K; Oku Y; Ono Y; Wakasu S; Haratake N; Tagawa T; Nakashima N; Mori M
Sci Rep; 2023 Sep; 13(1):15683. PubMed ID: 37735585
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
3. An Artificial Intelligence Model for Predicting 1-Year Survival of Bone Metastases in Non-Small-Cell Lung Cancer Patients Based on XGBoost Algorithm.
Huang Z; Hu C; Chi C; Jiang Z; Tong Y; Zhao C
Biomed Res Int; 2020; 2020():3462363. PubMed ID: 32685470
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
6. Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study.
Kinoshita F; Tagawa T; Yamashita T; Takenaka T; Matsubara T; Toyokawa G; Takada K; Oba T; Osoegawa A; Yamazaki K; Takenoyama M; Shimokawa M; Nakashima N; Mori M
PLoS One; 2021; 16(9):e0256894. PubMed ID: 34473762
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid to lymphocyte ratio: A novel prognostic biomarker for surgically resected early-stage lung cancer. A propensity score matching analysis.
Yang Z; Li S; Zhao L; Lv W; Ju J; Zhang W; Li J; Che G
Clin Chim Acta; 2020 Apr; 503():35-44. PubMed ID: 31926813
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
[TBL] [Abstract][Full Text] [Related]
9. Postoperative prognostic nutritional index as a prognostic factor after non-small cell lung cancer surgery.
Hayasaka K; Shiono S; Suzuki K; Endoh M; Okada Y
Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1163-1171. PubMed ID: 32328993
[TBL] [Abstract][Full Text] [Related]
10. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
Rajaram R; Correa AM; Xu T; Nguyen QN; Antonoff MB; Rice D; Mehran R; Roth J; Walsh G; Swisher S; Hofstetter WL; Vaporciyan A; Cascone T; Tsao AS; Papadimitrakopoulou VA; Gandhi S; Liao Z; Sepesi B
Clin Lung Cancer; 2020 Jul; 21(4):e294-e301. PubMed ID: 32089476
[TBL] [Abstract][Full Text] [Related]
11. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
[TBL] [Abstract][Full Text] [Related]
12. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
14. A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients.
Wang W; Zhou J
Cancer Control; 2023; 30():10732748231197973. PubMed ID: 37703536
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study.
Takada K; Takamori S; Matsubara T; Haratake N; Akamine T; Kinoshita F; Ono Y; Wakasu S; Tanaka K; Oku Y; Oba T; Osoegawa A; Tagawa T; Takenoyama M; Shimokawa M; Oda Y; Mori M
PLoS One; 2020; 15(11):e0241580. PubMed ID: 33137158
[TBL] [Abstract][Full Text] [Related]
17. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Spaggiari L; Ratto GB; Filosso PL; Facciolo F
Eur J Cardiothorac Surg; 2019 Mar; 55(3):405-412. PubMed ID: 30202953
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
19. Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis.
Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F
Clin Lung Cancer; 2020 Sep; 21(5):464-471.e1. PubMed ID: 32389508
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]